| |
| |
|
| Insider
Information: |
Deerfield International Ltd |
| Relationship: |
Possible Member of 10%... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
40,000 |
|
|
Indirect Shares
|
13,205,139 |
|
|
| Direct
Value |
$30,500 |
|
|
|
Indirect Value
|
$3,909,084 |
|
|
| Total
Shares |
13,245,139 |
|
|
| Total
Value |
$3,939,584 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Par Pharmaceutical Companies Inc |
PRX |
Possible Member of 10%... |
2006-07-18 |
15,000 |
2009-08-18 |
3,464,000 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
10% Owner |
|
0 |
2007-10-19 |
3,595,492 |
Premium* |
|
|
Salix Pharmaceuticals Ltd |
SLXP |
Possible Member of 10%... |
|
0 |
2009-09-10 |
2,941,480 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
Possible Member of 10%... |
2011-05-26 |
25,000 |
2011-05-26 |
3,204,167 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RIGL |
Rigel Pharmaceuticals Inc |
Possible Member of 10% Group |
– – • |
2011-05-26 |
4 |
B |
$8.00 |
$5,200,000 |
I/I |
650,000 |
3,204,167 |
1.5 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-09-10 |
4 |
S |
$13.01 |
$9,773,011 |
I/I |
(744,060) |
2,941,480 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-09-09 |
4 |
S |
$12.96 |
$2,215,238 |
I/I |
(170,704) |
3,437,936 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-09-08 |
4 |
S |
$12.98 |
$1,443,233 |
I/I |
(111,189) |
3,608,640 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-08-19 |
4 |
S |
$12.98 |
$141,755 |
I/I |
(10,921) |
3,719,829 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-08-18 |
4 |
S |
$12.96 |
$907,200 |
I/I |
(70,000) |
3,730,750 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Possible Member of 10% Group |
– – • |
2009-08-18 |
4 |
S |
$17.48 |
$2,498,275 |
I/I |
(141,845) |
2,108,213 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Possible Member of 10% Group |
– – • |
2009-08-17 |
4 |
S |
$17.47 |
$1,742,866 |
I/I |
(98,571) |
2,250,058 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-07-29 |
4 |
S |
$12.55 |
$186,393 |
I/I |
(14,852) |
3,800,750 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-07-29 |
4 |
S |
$12.55 |
$124,258 |
I/I |
(9,901) |
2,176,124 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-07-28 |
4 |
S |
$12.98 |
$1,469,102 |
I/I |
(113,182) |
3,815,602 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-07-28 |
4 |
S |
$12.98 |
$979,315 |
I/I |
(75,448) |
2,186,025 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2009-07-27 |
4 |
S |
$13.11 |
$1,890,842 |
I/I |
(144,229) |
3,928,784 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2008-12-31 |
4 |
B |
$8.54 |
$601,237 |
I/I |
69,050 |
3,957,249 |
1.5 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2008-12-30 |
4 |
B |
$8.47 |
$847,000 |
I/I |
100,000 |
3,913,471 |
1.5 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2008-12-29 |
4 |
B |
$8.47 |
$1,775,148 |
I/I |
208,400 |
3,850,070 |
1.5 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2008-12-23 |
4 |
B |
$8.54 |
$5,124 |
I/I |
600 |
3,717,944 |
1.5 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2008-12-22 |
4 |
B |
$8.33 |
$1,184,479 |
I/I |
140,306 |
3,717,563 |
1.5 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2008-12-19 |
4 |
B |
$8.48 |
$856,488 |
I/I |
100,912 |
3,628,607 |
1.5 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2008-12-18 |
4 |
B |
$8.47 |
$718,638 |
I/I |
84,535 |
3,564,628 |
1.5 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2008-12-17 |
4 |
B |
$8.04 |
$134,268 |
I/I |
16,700 |
3,511,031 |
1.5 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Possible Member of 10% Group |
– – • |
2008-12-16 |
4 |
B |
$7.78 |
$1,656,728 |
I/I |
212,947 |
3,500,443 |
1.5 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
Possible Member of 10% Group |
– – • |
2008-11-25 |
4 |
S |
$10.40 |
$1,811,510 |
I/I |
(173,500) |
2,348,629 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
10% Owner |
– – • |
2008-11-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,309,436 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
10% Owner |
– – • |
2008-11-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,877,916 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
